115 related articles for article (PubMed ID: 18340322)
41. Comparison between angiotensin-converting enzyme inhibitors and angiotensin receptor blockers on the risk of myocardial infarction, stroke and death: a meta-analysis.
Reboldi G; Angeli F; Cavallini C; Gentile G; Mancia G; Verdecchia P
J Hypertens; 2008 Jul; 26(7):1282-9. PubMed ID: 18550998
[TBL] [Abstract][Full Text] [Related]
42. Use of evidence-based therapies after discharge among elderly patients with acute myocardial infarction.
Austin PC; Tu JV; Ko DT; Alter DA
CMAJ; 2008 Oct; 179(9):895-900. PubMed ID: 18936454
[TBL] [Abstract][Full Text] [Related]
43. Antiplatelet therapy use after discharge among acute myocardial infarction patients with in-hospital bleeding.
Wang TY; Xiao L; Alexander KP; Rao SV; Kosiborod MN; Rumsfeld JS; Spertus JA; Peterson ED
Circulation; 2008 Nov; 118(21):2139-45. PubMed ID: 18981304
[TBL] [Abstract][Full Text] [Related]
44. Baseline low-density lipoprotein cholesterol is an important predictor of the benefit of intensive lipid-lowering therapy: a PROVE IT-TIMI 22 (Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis In Myocardial Infarction 22) analysis.
Giraldez RR; Giugliano RP; Mohanavelu S; Murphy SA; McCabe CH; Cannon CP; Braunwald E
J Am Coll Cardiol; 2008 Sep; 52(11):914-20. PubMed ID: 18772061
[TBL] [Abstract][Full Text] [Related]
45. Improving outcomes in high-risk populations using REACH: an inpatient cardiac risk reduction program.
Patel PV; Gilski D; Morrison J
Crit Pathw Cardiol; 2009 Sep; 8(3):112-8. PubMed ID: 19726930
[TBL] [Abstract][Full Text] [Related]
46. Relationship between cardiac rehabilitation and survival after acute cardiac hospitalization within a universal health care system.
Alter DA; Oh PI; Chong A
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):102-13. PubMed ID: 19165089
[TBL] [Abstract][Full Text] [Related]
47. Current use of beta blockers in patients with reactive airway disease who are hospitalized with acute coronary syndromes.
Olenchock BA; Fonarow GG; Pan W; Hernandez A; Cannon CP;
Am J Cardiol; 2009 Feb; 103(3):295-300. PubMed ID: 19166678
[TBL] [Abstract][Full Text] [Related]
48. Influence of hospital length of stay for heart failure on quality of care.
Krantz MJ; Tanner J; Horwich TB; Yancy C; Albert NM; Hernandez AF; Dai D; Fonarow GC;
Am J Cardiol; 2008 Dec; 102(12):1693-7. PubMed ID: 19064026
[TBL] [Abstract][Full Text] [Related]
49. Targeting residual cardiovascular risk: raising high-density lipoprotein cholesterol levels.
Hausenloy DJ; Yellon DM
Heart; 2008 Jun; 94(6):706-14. PubMed ID: 18480348
[TBL] [Abstract][Full Text] [Related]
50. Factors associated with the discontinuation of evidence-based cardiovascular therapies in patients with stable coronary artery disease: a primary care perspective.
Mostaza JM; Lahoz C; Martín-Jadraque R; Sanmartín MA; Vicente I; Tranche S; Taboada M; Mantilla T; Monteiro B; Sanchez-Zamorano MA;
Eur J Cardiovasc Prev Rehabil; 2009 Feb; 16(1):34-8. PubMed ID: 19237995
[TBL] [Abstract][Full Text] [Related]
51. Managed care interventions for improving outcomes in acute heart failure syndromes.
Khan SS; Gheorghiade M; Dunn JD; Pezalla E; Fonarow GC
Am J Manag Care; 2008 Dec; 14(12 Suppl Managed):S273-86; quiz S287-91. PubMed ID: 19166273
[TBL] [Abstract][Full Text] [Related]
52. Determining the most appropriate components for a composite clinical trial outcome.
Bethel MA; Holman R; Haffner SM; Califf RM; Huntsman-Labed A; Hua TA; McMurray J
Am Heart J; 2008 Oct; 156(4):633-40. PubMed ID: 18926145
[TBL] [Abstract][Full Text] [Related]
53. Proteinuria, chronic kidney disease, and the effect of an angiotensin receptor blocker in addition to an angiotensin-converting enzyme inhibitor in patients with moderate to severe heart failure.
Anand IS; Bishu K; Rector TS; Ishani A; Kuskowski MA; Cohn JN
Circulation; 2009 Oct; 120(16):1577-84. PubMed ID: 19805651
[TBL] [Abstract][Full Text] [Related]
54. [Adherence to cardioprotective medications in coronary heart disease].
Scardi S; Mazzone C; Di Lenarda A
G Ital Cardiol (Rome); 2009 Apr; 10(4):241-8. PubMed ID: 19475879
[TBL] [Abstract][Full Text] [Related]
55. Age- and gender-related differences in quality of care and outcomes of patients hospitalized with heart failure (from OPTIMIZE-HF).
Fonarow GC; Abraham WT; Albert NM; Stough WG; Gheorghiade M; Greenberg BH; O'Connor CM; Sun JL; Yancy C; Young JB;
Am J Cardiol; 2009 Jul; 104(1):107-15. PubMed ID: 19576329
[TBL] [Abstract][Full Text] [Related]
56. Effects of angiotensin-converting enzyme inhibitor or angiotensin receptor blocker therapy after hospital discharge on subsequent rehospitalization for acute myocardial infarction and heart failure.
Hess G; Preblick R; Hill J; Plauschinat CA; Yaskin J
Congest Heart Fail; 2009; 15(4):170-5. PubMed ID: 19627290
[TBL] [Abstract][Full Text] [Related]
57. The burden of peripheral artery disease and the role of antiplatelet therapy.
Aronow H; Hiatt WR
Postgrad Med; 2009 Jul; 121(4):123-35. PubMed ID: 19641278
[TBL] [Abstract][Full Text] [Related]
58. [Arterial hypertension and dyslipidemia in patients with chronic kidney disease (CKD). Anti-platelet aggregation. Goal oriented treatment].
Cases Amenós A; Goicoechea Diezhandiño M; de Alvaro Moreno F
Nefrologia; 2008; 28 Suppl 3():39-48. PubMed ID: 19018737
[TBL] [Abstract][Full Text] [Related]
59. Hypercholesterolemia treatment patterns and low-density lipoprotein cholesterol monitoring in patients with a diagnosis of atherosclerosis in clinical practice.
Davidson MH; Gandhi SK; Ohsfeldt RL; Fox KM
Am J Med; 2009 Jan; 122(1 Suppl):S51-9. PubMed ID: 19110088
[TBL] [Abstract][Full Text] [Related]
60. Treating to low-density lipoprotein goal: a tool for initiating and optimizing lipid-lowering therapy in patients with atherosclerosis or similar risk.
Fonarow GC; Watson KE
Crit Pathw Cardiol; 2005 Dec; 4(4):174-6. PubMed ID: 18340204
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
